Serum bromide has been used in the past to measure extracellular fluid volume in infants. In this report, a modification and refinement of a previously described spectrophotometric assay suitable for determining bromide levels in blood is presented. The assay involves sample deproteinization with perchloric acid followed by spectrophotometric analysis of the complexes formed by the reaction between sodium bromide and gold chloride. Linear standard curves were obtained by diluting 1:2 with pooled serum at the following bromide concentrations: 10, 20, 30 and 40 mg%. Intra-and interassay variation using this technique was extremely small (n = 6, correlation coefficient, 0.995, and n = 5, correlation coefficient, 0.988, respectively). For toxicological analysis, a linear standard curve was derived from sodium bromide standards at the following concentrations: 40, 60, 80, and 100 mg%. The reproducibility and reliability of this assay have been excellent and the correlaton with neutron activation analysis was excellent. The assay is easily adapted for the analysis of large numbers of samples, is easy to perform, and requires only small sample volumes.
INTRODUCTION
Measurement of extracellular fluid volume in infants is very helpful in the evaluation of various treatment programs such as total parental nutrition and the fluid resuscitation of shock states. In the adult, these studies are frequently performed using radioactive isotopes. In infants, however, the use of radioactive isotopes is precluded. The nonradioactive isotope sodium bromide has been used in the past to measure extracellular fluid in infants [l-3] . However, several different techniques have been reported for determining the bromide ion concentration in biological fluids. Direct spectroscopy [4] , neutron activiation analysis [ 51, diffusion techniques 161, and ion selective electrodes [7] mide (NaBr) solution in a dose of 4 ml/kg body weight was injected into the femoral vein and blood samples were collected from the femoral artery at the following time intervals: prior to injection of the NaBr and every 30 min after injection for a total of 3 hr. The blood samples were centrifuged at 2000 rpm for 15 min at 4°C and the serum removed.
Sodium chloride was included in the assay system in order to control for a slight degree of cross-reactivity between chloride and bromide. One, 5, and 10% NaCl concentrations were assayed for bromide (n = 8) to determine if NaCl cross-reacts significantly in this assay system. The following values were obtained: 0.233 f 0.87, 0.50 + 0.84, and 0.46 + 0.59 mg% (mean f SD). From these data, it was concluded that NaCl does not significantly interfere with the bromide determination and that inclusion of 1.0 cc of 0.6% NaCl in the assay system protects against chloride variation between samples.
It was observed that serum samples respond differently than standards in the assay. Serum samples reach a peak absorbance 3 min after the addition of the supernatant to the AuC&-NaCl solution. Following this peak, the samples continue to lose absorbance over time (Fig. 2) . The standards
The assay is performed in the following way: 0.5 cc of a standard or unknown sample is deproteinized in 1.0 cc of ice cold perchloric acid (0.6 M). Following centrifugation at 2000 rpm at 4°C for 5 mitt, 1 cc of supernatant is transferred to a test tube containing 1.0 cc of 0.6% sodium chloride (NaCl) and 1.0 cc of 0.0375% gold chloride (AuC&). Absorbance is recorded with a spectrophotometer at 350 nm wavelength exactly 3 min after the addition of the supernatant to the NaCl-AuC& solution. The spectrophotometer is zeroed with distilled water. The standards used in the assay are 5, 10, 15, and 20 mg% NaBr made up with double-distilled deionized water. The assay is linear up to a concentration of NaBr of 40 mg%. All curves were derived from linear regression analysis. 
RESULTS
A typical standard curve is shown in Fig.  1 . The correlation coefficient for this data is 0.997 (n = 7). The results of the analysis of the pooled serum were quite reproducible with means + standard deviations of 0.166 f 0.33 and 13.17 + 0.52 mg% (n = 10) for a typical low and high pooled serum concentration. No significant differences were observed between plasma and serum samples. Figure 3 shows the intraassay variation using this technique (n = 6, correlation coefficient, 0.995). Interassay variation using these standard samples is depicted in Fig. 4 (n = 5, correlation coefficient, 0.988). An example of a typical group of samples taken from an experimental animal and assayed using the described method and nuclear activation analysis is presented in Fig. 5 .
DISCUSSION
This modification of the spectrophotometric assay for serum bromide differs from the method described by Cassady in several important aspects. First, deproteinization of the serum sample with perchloric acid rather than zinc hydroxide is important since incomplete protein precipitation often results in spurious data and poor reproducibility. By keeping the entire procedure in an acid environment, the reliability of the assay system is greatly improved. Second, it is important to read the peak absorbance value at 3 min, rather than at 15 min, because significant decreases in absorbance occur over time. Lastly, it is necessary to use standards diluted 1:2 with pooled serum in order to achieve the correct bromide value. Otherwise, the bromide concentration is falsely low. This was substantiated by comparison with neutron activation analysis.
The attractiveness of this assay prompted us to evaluate its use at higher serum concentrations of bromide such as occur with medication overdose. For toxicological analysis, a linear relationship exists using standards at the following NaBr concentrations: 40,60,80, and 100 mg%. The only procedure modification required with this range of bromide standards was the use of 2 cc of 0.0375% AuC& instead of 1 cc as was described previously. With these modifications, a linear curve is obtained with bromide concentrations between 40 and 100 mg%, an appropriate range for toxicological assays.
The reproducibility and reliability of this assay has been excellent and the correlation with neutron acitivation analysis has been very close. The assay is easily adapted for large numbers of samples by carefully staggering the addition of the supematant to the AuC&-NaCl solution at 15-set intervals and by analyzing the samples in blocks of 12 during each 3-min interval.
